Finance
Pharmaceutical company reports 2003 financial results
Published in Biotech Business Week, March 15th, 2004
Pozen reported a net loss of $1.6 million, or $0.06 per share, for the fourth quarter of 2003 compared with a net loss of $5.7 million, or $0.20 per share, for the fourth quarter of 2002. Pozen's net loss was $14.9 million, or $0.52 per common share for 2003, as compared to $24.6 million or $0.87 per common share for 2002.
For the fourth quarter of 2003, Pozen reported revenue of $1.8 million. Revenue for the 12 months ended December 31, 2003, totaled $3.7 million. Pozen did not report any revenue during 2002. Revenue for the fourth quarter and the 12 months...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Information Technology
Biometric products permit remote acquisition, management of patients' data - Liver Cancer
Some normal human hepatocytes undergo apoptosis mediated by TRAIL-R1 and R2 - Contraception
FDA extends Plan B emergency contraceptive PDUFA date - Epilepsy
Licensing agreement signed for Rufinamide - Purchasing Agreements
Novation signs agreement for blood-gas analyzers - Sports Medicine Trends
Kids, older boomers driving $3B first aid and sports medicine markets - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
